<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Surg Case Rep</journal-id><journal-id journal-id-type="iso-abbrev">Int J Surg Case Rep</journal-id><journal-title-group><journal-title>International Journal of Surgery Case Reports</journal-title></journal-title-group><issn pub-type="epub">2210-2612</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30852372</article-id><article-id pub-id-type="pmc">6409421</article-id><article-id pub-id-type="publisher-id">S2210-2612(19)30093-8</article-id><article-id pub-id-type="doi">10.1016/j.ijscr.2019.02.032</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A case of synchronous advanced gastric cancer and locally advanced prostate cancer with combined laparoscopic and robotic surgery: A case report</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Imagami</surname><given-names>Toru</given-names></name><email>i-toru@nagoya.tokushukai.or.jp</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author"><name><surname>Takayama</surname><given-names>Satoru</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Hattori</surname><given-names>Taku</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Matsui</surname><given-names>Ryohei</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Sakamoto</surname><given-names>Masaki</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Kani</surname><given-names>Hisanori</given-names></name><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Kurokawa</surname><given-names>Satoshi</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Fujiwara</surname><given-names>Tsuyoshi</given-names></name><xref rid="aff0010" ref-type="aff">b</xref></contrib></contrib-group><aff id="aff0005"><label>a</label>Department of Surgery, Nagoya Tokushukai General Hospital, Kasugai City, Japan</aff><aff id="aff0010"><label>b</label>Department of Urology, Nagoya Tokushukai General Hospital, Kasugai City, Japan</aff><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author at: Department of Surgery, Nagoya Tokushukai General Hospital, 2-52 Kouzouji-cho kita, Kasugai City, Aichi, 487-0016, Japan. <email>i-toru@nagoya.tokushukai.or.jp</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>01</day><month>3</month><year>2019</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>01</day><month>3</month><year>2019</year></pub-date><volume>56</volume><fpage>82</fpage><lpage>85</lpage><history><date date-type="received"><day>23</day><month>1</month><year>2019</year></date><date date-type="rev-recd"><day>7</day><month>2</month><year>2019</year></date><date date-type="accepted"><day>18</day><month>2</month><year>2019</year></date></history><permissions><copyright-statement>&#x000a9; 2019 The Author(s)</copyright-statement><copyright-year>2019</copyright-year><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract abstract-type="author-highlights" id="abs0005"><title>Highlights</title><p><list list-type="simple" id="lis0005"><list-item id="lsti0005"><label>&#x02022;</label><p id="par0005">The optimal management for synchronous advanced cancer remains controversial.</p></list-item><list-item id="lsti0010"><label>&#x02022;</label><p id="par0010">Multidisciplinary treatment strategies are important for synchronous advanced cancer.</p></list-item><list-item id="lsti0015"><label>&#x02022;</label><p id="par0015">Combined laparoscopic and robotic surgery allows minimally invasive resection.</p></list-item><list-item id="lsti0020"><label>&#x02022;</label><p id="par0020">Simultaneous endoscopic surgery is recommended for synchronous advanced cancer.</p></list-item></list></p></abstract><abstract id="abs0010"><sec><title>Introduction</title><p>The optimal management strategy for synchronous gastric cancer (GC) and prostate cancer (PCa) remains unclear, particularly in cases in which two cancers are progressive.</p></sec><sec><title>Presentation of case</title><p>A 68-year-old man diagnosed with synchronous advanced GC and locally advanced PCa was referred to our institution. Laparoscopic total gastrectomy (LTG) and robotic-assisted radical prostatectomy were simultaneously performed. The postoperative course was similar to the standard postoperative course of LTG alone. Pathological diagnoses were T3N3aM0 gastric adenocarcinoma and T3N0M0 prostatic adenocarcinoma. Adjuvant chemotherapy and adjuvant androgen deprivation therapy (ADT) for GC and PCa were initiated on postoperative days 15 and 27, respectively. Six months subsequent to surgery, the patient received adjuvant chemotherapy and ADT, and no evidence of cancer recurrence was observed.</p></sec><sec><title>Discussion</title><p>In terms of survival, curative resection with adjuvant therapy is advantageous for patients with advanced GC or locally advanced PCa. At present, treatment for synchronous cancer should be combined with optimal management for individual cancers. Minimally invasive surgery may play an important role in the multidisciplinary treatment of synchronous advanced cancer.</p></sec><sec><title>Conclusion</title><p>Combined laparoscopic and robotic surgery for synchronous GC and PCa allows for minimally invasive radical resection and appropriate adjuvant therapy.</p></sec></abstract><kwd-group id="kwd0005"><title>Abbreviations</title><kwd>GC, gastric cancer</kwd><kwd>PCa, prostate cancer</kwd><kwd>LTG, laparoscopic total gastrectomy</kwd><kwd>RARP, robotic-assisted radical prostatectomy</kwd><kwd>ADT, androgen deprivation therapy</kwd><kwd>PSA, prostate-specific antigen</kwd><kwd>CT, computed tomography</kwd><kwd>MRI, magnetic resonance imaging</kwd></kwd-group><kwd-group id="kwd0010"><title>Keywords</title><kwd>Synchronous cancer</kwd><kwd>Gastric cancer</kwd><kwd>Combined laparoscopic surgery</kwd><kwd>Multidisciplinary treatment for synchronous cancer</kwd><kwd>Case report</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><label>1</label><title>Introduction</title><p id="par0025">In Japan, the incidence rate of synchronous gastric cancer (GC) and prostate cancer (PCa) is 2% [<xref rid="bib0005" ref-type="bibr">1</xref>,<xref rid="bib0010" ref-type="bibr">2</xref>]. Most synchronous cancers are detected during preoperative workup [<xref rid="bib0015" ref-type="bibr">3</xref>]. Improvement in preoperative diagnostic techniques may increase the diagnostic frequency of synchronous GC and PCa. However, an optimal management strategy for synchronous GC and PCa remains unclear, particularly in cases in which two cancers are progressive.</p><p id="par0030">Recently, endoscopic surgery has been widely used for GC or PCa. In contrast, only few studies on simultaneous endoscopic surgery for synchronous GC and PCa have been reported [<xref rid="bib0005" ref-type="bibr">1</xref>]. At our center, laparoscopic total gastrectomy (LTG) combined with robotic-assisted radical prostatectomy (RARP) is performed for synchronous GC and PCa. Postoperative therapy is applied for each cancer. In this study, a multidisciplinary treatment strategy for synchronous advanced GC and locally advanced PCa is presented. In addition, a pertinent literature review was conducted. This work has been reported in line with the SCARE criteria [<xref rid="bib0020" ref-type="bibr">4</xref>].</p></sec><sec id="sec0010"><label>2</label><title>Presentation of case</title><p id="par0035">A 68-year-old male with an unremarkable medical history was referred to our hospital for the screening of GC and PCa. His physical examination result was not significant. Gastroscopy revealed a type 3 tumor on the greater curvature of the stomach (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>a). He was pathologically diagnosed with gastric adenocarcinoma (tub2). Contrast-enhanced computed tomography (CT) scan revealed metastasis to the peri-gastric lymph nodes. However, no evidence of distant metastasis was observed. According to the screening results for PCa, the serum concentration of prostate-specific antigen (PSA) increased to 26&#x02009;ng/mL. Magnetic resonance imaging (MRI) and prostatic biopsy revealed prostatic adenocarcinoma, with a Gleason score of 4&#x02013;5. Based on CT scan and MRI findings, local progression of PCa was observed (<xref rid="fig0005" ref-type="fig">Fig. 1</xref>b). The adenocarcinomas were pathologically diagnosed as separate cancers. His preoperative diagnosis was synchronous T3N2M0 gastric adenocarcinoma and T3N0M0 prostatic adenocarcinoma. According to the Japanese guideline, neoadjuvant chemotherapy (NAC) was not recommended. His prognosis based on GC, and GC treatment, not PCa treatment, should be prioritized. Based on consultation from surgeons and urologists, we considered the following options: (1) simultaneous surgery followed by adjuvant chemotherapy and (2) surgery and adjuvant chemotherapy for GC followed by prostatectomy. According to our previous experience, simultaneous resection of GC and PCa was proposed. The patient agreed with our decision and underwent LTG combined with RARP. The port arrangement is depicted in <xref rid="fig0010" ref-type="fig">Fig. 2</xref>.<fig id="fig0005"><label>Fig. 1</label><caption><p>Preoperative image findings.</p><p>(a) Gastroscopy revealed a type 3 tumor on the greater curvature of the stomach.</p><p>(b) Prostate cancer was suspected to spread out of the capsule by contrast-enhanced CT.</p></caption><alt-text id="at0110">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig><fig id="fig0010"><label>Fig. 2</label><caption><p>Port arrangement (<inline-graphic xlink:href="fx1.gif"/>: 12&#x02009;mm trocar, &#x025cf;: 8&#x02009;mm trocar, &#x025cb;: 5&#x02009;mm trocar).</p><p>Surgeons inserted additional two 5&#x02009;mm trocars on left and right upper abdomen.</p></caption><alt-text id="at0115">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig></p><p id="par0040">Under general anesthesia, the urologists initiated RARP while the patient was on lithotomy position and routinely used six ports. After resection of the prostate and urethrovesical anastomosis, the surgeons inserted additional ports and performed LTG with D2 lymph node dissection, as described in the Japanese classification of GC. Moreover, they extended the umbilical wound and retrieved the resected stomach and prostate. The jejunum that is located 30&#x02009;cm distal from the ligament of Treitz was transected. After creating a 30-cm Roux-en-Y limb, Y anastomosis was performed via side-to-side jejunojejunostomy. Intracorporeal esophagojejunostomy was carried out using the overlap technique. The surgery lasted for 519&#x02009;min, and the total volume of blood loss was 250&#x02009;mL. Oral intake was initiated on postoperative day 2, and the patient was discharged on postoperative day 9. The postoperative course was similar to the standard postoperative course of LTG alone at our hospital. The pathological diagnoses were T3N3aM0 gastric adenocarcinoma and T3aN0M0 prostatic adenocarcinoma (<xref rid="fig0015" ref-type="fig">Fig. 3</xref>).<fig id="fig0015"><label>Fig. 3</label><caption><p>Pathological findings are shown. Each cancer was pathologically diagnosed as separate adenocarcinoma.</p><p>(a) Gastric cancer;</p><p>Adenocarcinoma, U, Gre, type 2, 40&#x02009;mm&#x02009;&#x000d7;&#x02009;40&#x02009;mm, tub2&#x02009;&#x0003e;&#x02009;por2, pT3(SS), sci, INFc, ly3, v3, pN3a, pPM0, pDM0.</p><p>(b) Prostate cancer;</p><p>Adenocarcinoma, Gleason score 4&#x02009;+&#x02009;4&#x02009;=&#x02009;8 with tertiary pattern 5, pT3a, ly0, v0, pn1, sv0.</p></caption><alt-text id="at0120">Fig. 3</alt-text><graphic xlink:href="gr3"/></fig></p><p id="par0045">Adjuvant chemotherapy with S-1 for GC was started on postoperative day 15. In addition, ADT with bicalutamide for PCa was initiated on postoperative day 27. Six months subsequent to surgery, his body weight decreased only by 3&#x02009;kg compared to the preoperative weight. He complained of edema in both legs. However, no side effects due to chemotherapy were noted. The patient continually received adjuvant chemotherapy and ADT, and no evidence of cancer recurrence was observed. We planned to continue with adjuvant chemotherapy until 1&#x02009;year after surgery. Laboratory data and diagnosis obtained via CT scan and ultrasonography will be used for the evaluation of recurrence 1&#x02009;year after surgery.</p></sec><sec id="sec0015"><label>3</label><title>Discussion</title><p id="par0050">Periodic cancer screening and radical resection with regional lymph node dissection have significantly improved the clinical outcomes of patients with GC [<xref rid="bib0015" ref-type="bibr">3</xref>,<xref rid="bib0025" ref-type="bibr">5</xref>]. However, the synchronous presence of another primary malignancy negatively affected the clinical outcomes of GC survivors [<xref rid="bib0025" ref-type="bibr">5</xref>,<xref rid="bib0030" ref-type="bibr">6</xref>]. Kim et al. have hypothesized that synchronous cancers prevented the proper treatment of GC5. To further improve the prognosis, individual cases of GC with other primary malignancies must be discussed.</p><p id="par0055">In terms of technical feasibility and oncological safety, simultaneous laparoscopy combined with resection is the best option for patients with co-existing abdominal lesions [<xref rid="bib0035" ref-type="bibr">7</xref>]. We have previously reported about the advantages of combined laparoscopic and robotic resection for synchronous colorectal cancer and PCa [<xref rid="bib0040" ref-type="bibr">8</xref>]. Based on such experience, combined LTG and RARP were selected.</p><p id="par0060">In Japan, curative gastrectomy is the primary treatment strategy for advanced GC, and adjuvant chemotherapy is required to improve overall and relapse-free survival rates [<xref rid="bib0045" ref-type="bibr">9</xref>]. Multidisciplinary treatment strategies are important in improving quality of life and survival rates in patients with multiple primary cancers [<xref rid="bib0050" ref-type="bibr">10</xref>]. The prompt administration of adjuvant chemotherapy promotes early recovery after surgery. Some studies have reported that combined laparoscopic surgeries can decrease the length of hospital stay and allow for an earlier return in performing daily activities [<xref rid="bib0055" ref-type="bibr">11</xref>,<xref rid="bib0060" ref-type="bibr">12</xref>]. In the present study, adjuvant chemotherapy was initiated on postoperative day 15. Regarding adjuvant chemotherapy, simultaneous endoscopic surgical intervention is advantageous for synchronous GC with another primary cancer.</p><p id="par0065">Currently, in the Japanese guideline, NAC is not recommended for GC with peri-gastric lymph node metastasis alone. A clinical trial of NAC for advanced GC is being conducted, and based on its result, NAC may be recommended. Even in such situation, simultaneous resection is recommended after NAC.</p><p id="par0070">Two-time surgery, such as PARP followed by LTG, may cause GC metastasis due to initial surgical invasion. Various perioperative changes have been proposed to prevent metastases after surgery [<xref rid="bib0065" ref-type="bibr">13</xref>]. Fukaya et al. have reported that immunosuppression due to the first invasive surgery may lead to progression of other untreated cancers [<xref rid="bib0070" ref-type="bibr">14</xref>]. This hypothesis may be a drawback to the two-time surgery for synchronous cancers. For GC with another primary cancer, surgical resection of GC alone may promote the progression of secondary cancer.</p><p id="par0075">The development of metastasis is directly proportional to the magnitude of surgical stress [<xref rid="bib0075" ref-type="bibr">15</xref>,<xref rid="bib0080" ref-type="bibr">16</xref>]. Simultaneous resection of synchronous abdominal lesions is more likely to benefit patients by reducing psychological and physiological stressors correlated to a second surgery [<xref rid="bib0035" ref-type="bibr">7</xref>]. Minimally invasive surgery will play an important role in the improvement of immunosuppression and promotion of early recovery from perioperative invasion.</p><p id="par0080">Currently, except in small facilities, robotic surgery for GC is not covered by the national health insurance program in Japan; therefore, we usually perform laparoscopic surgery. The postoperative course of the patient in the present study was not inferior to that of robotic surgery alone, as reported by Yoo et al. [<xref rid="bib0005" ref-type="bibr">1</xref>].</p><p id="par0085">In a previous study, radical prostatectomy was associated with a lower all-cause mortality with a PSA value &#x0003e;10&#x02009;ng/mL or with high-risk tumors [<xref rid="bib0085" ref-type="bibr">17</xref>]. However, patients with pT3N0 PCa may experience disease relapse, and radical prostatectomy alone may not be an effective treatment [<xref rid="bib0090" ref-type="bibr">18</xref>]. In Asia, ADT is commonly used as a salvage treatment for recurrence after radical prostatectomy [<xref rid="bib0095" ref-type="bibr">19</xref>]. Significant local control via prostatectomy can improve quality of life, and adjuvant hormone therapy is significantly advantageous in terms of survival [<xref rid="bib0100" ref-type="bibr">20</xref>]. In this case, RARP with adjuvant ADT has been effective in the treatment of locally advanced PCa, and it did not interfere with synchronous GC treatment.</p><p id="par0090">The primary limitation of this study is the fact that it is a single case report. Therefore, large-scale studies must be conducted. At present, treatment for synchronous cancer should be combined with optimal management for individual cancers.</p></sec><sec id="sec0020"><label>4</label><title>Conclusion</title><p id="par0095">Synchronous advanced GC and locally advanced PCa were successfully treated. Combined LTG and RARP allowed for minimally invasive radical resection and appropriate adjuvant therapy. Therefore, simultaneous endoscopic surgery is recommended for the treatment of synchronous cancers, including synchronous advanced GC and locally advanced PCa.</p></sec><sec id="sec0025"><title>Conflicts of interest</title><p id="par0100">The authors have no conflict of interest to declare.</p></sec><sec id="sec0030"><title>Sources of funding</title><p id="par0105">This study did not receive any specific grant from funding agencies in the pubic, commercial, or not-for-profit sectors.</p></sec><sec id="sec0035"><title>Ethical approval</title><p id="par0110">This study was approved by the ethics committee in Nagoya Tokushukai General Hospital (Institutional Review Board approval 2019-01-002).</p></sec><sec id="sec0040"><title>Consent</title><p id="par0115">Written informed consent was obtained from patient for publication of this case report.</p></sec><sec id="sec0045"><title>Author&#x02019;s contribution</title><p id="par0120">TI, TH, MS and SK performed operation. TI drafted the manuscript. ST participated in the correction of the manuscript. All authors approved the final manuscript.</p></sec><sec id="sec0050"><title>Registration of research studies</title><p id="par0125">No research study involved in this case report. Not applicable.</p></sec><sec id="sec0055"><title>Guarantor</title><p id="par0130">Toru Imagami.</p></sec><sec id="sec0060"><title>Provenance and peer review</title><p id="par0135">Not commissioned, externally peer reviewed.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><label>1</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>J.</given-names></name><name><surname>Jeong</surname><given-names>W.</given-names></name><name><surname>Oh</surname><given-names>C.K.</given-names></name><name><surname>Lorenzo</surname><given-names>E.I.</given-names></name><name><surname>Lee</surname><given-names>Y.H.</given-names></name><name><surname>Rha</surname><given-names>K.H.</given-names></name></person-group><article-title>Double primary tumor of the stomach and the prostate managed robotically simultaneously</article-title><source>J. Rob. Surg.</source><volume>4</volume><issue>May (1)</issue><year>2010</year><fpage>53</fpage><lpage>55</lpage><comment>Epub 2010 Mar 18</comment></element-citation></ref><ref id="bib0010"><label>2</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Ikeda</surname><given-names>Y.</given-names></name><name><surname>Saku</surname><given-names>M.</given-names></name><name><surname>Kawanaka</surname><given-names>H.</given-names></name><name><surname>Nonaka</surname><given-names>M.</given-names></name><name><surname>Yoshida</surname><given-names>K.</given-names></name></person-group><article-title>Features of second primary cancer in patients with gastric cancer</article-title><source>Oncology</source><volume>65</volume><issue>2</issue><year>2003</year><fpage>113</fpage><lpage>117</lpage><pub-id pub-id-type="pmid">12931016</pub-id></element-citation></ref><ref id="bib0015"><label>3</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Eom</surname><given-names>B.W.</given-names></name><name><surname>Lee</surname><given-names>H.J.</given-names></name><name><surname>Yoo</surname><given-names>M.W.</given-names></name><name><surname>Cho</surname><given-names>J.J.</given-names></name><name><surname>Kim</surname><given-names>W.H.</given-names></name><name><surname>Yang</surname><given-names>H.K.</given-names></name><name><surname>Lee</surname><given-names>K.U.</given-names></name></person-group><article-title>Synchronous and metachronous cancers in patients with gastric cancer</article-title><source>J. Surg. Oncol.</source><volume>98</volume><issue>August (2)</issue><year>2008</year><fpage>106</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">18452218</pub-id></element-citation></ref><ref id="bib0020"><label>4</label><element-citation publication-type="journal" id="sbref0020"><person-group person-group-type="author"><name><surname>Agha</surname><given-names>R.A.</given-names></name><name><surname>Fowler</surname><given-names>A.J.</given-names></name><name><surname>Saetta</surname><given-names>A.</given-names></name><name><surname>Barai</surname><given-names>I.</given-names></name><name><surname>Rajmohan</surname><given-names>S.</given-names></name><name><surname>Orgill</surname><given-names>D.P.</given-names></name><name><surname>for the SCARE Group</surname></name></person-group><article-title>The SCARE statement: consensus-based surgical case report guidelines</article-title><source>Int. J. Surg.</source><volume>34</volume><year>2016</year><fpage>180</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">27613565</pub-id></element-citation></ref><ref id="bib0025"><label>5</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Takeuchi</surname><given-names>D.</given-names></name><name><surname>Koide</surname><given-names>N.</given-names></name><name><surname>Komatsu</surname><given-names>D.</given-names></name><name><surname>Okumura</surname><given-names>M.</given-names></name><name><surname>Suzuki</surname><given-names>A.</given-names></name><name><surname>Miyagawa</surname><given-names>S.</given-names></name></person-group><article-title>Relationships of obesity and diabetes mellitus to other primary cancers in surgically treated gastric cancer patients</article-title><source>Int. J. Surg.</source><volume>12</volume><issue>6</issue><year>2014</year><fpage>587</fpage><lpage>593</lpage><comment>Epub 2014 May 5</comment><pub-id pub-id-type="pmid">24802517</pub-id></element-citation></ref><ref id="bib0030"><label>6</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>C.</given-names></name><name><surname>Chon</surname><given-names>H.</given-names></name><name><surname>Kang</surname><given-names>B.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Jeung</surname><given-names>H.C.</given-names></name><name><surname>Chung</surname><given-names>H.</given-names></name><name><surname>Noh</surname><given-names>S.</given-names></name><name><surname>Rha</surname><given-names>S.</given-names></name></person-group><article-title>Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer</article-title><source>BMC Cancer</source><volume>13</volume><issue>August</issue><year>2013</year><fpage>394</fpage><pub-id pub-id-type="pmid">23967865</pub-id></element-citation></ref><ref id="bib0035"><label>7</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H.J.</given-names></name><name><surname>Choi</surname><given-names>G.S.</given-names></name><name><surname>Park</surname><given-names>J.S.</given-names></name><name><surname>Park</surname><given-names>S.Y.</given-names></name><name><surname>Jun</surname><given-names>S.H.</given-names></name></person-group><article-title>Simultaneous laparoscopic multi-organ resection combined with colorectal cancer: comparison with non-combined surgery</article-title><source>World J. Gastroenterol.</source><volume>18</volume><issue>February (8)</issue><year>2012</year><fpage>806</fpage><lpage>813</lpage><pub-id pub-id-type="pmid">22371641</pub-id></element-citation></ref><ref id="bib0040"><label>8</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Imagami</surname><given-names>T.</given-names></name><name><surname>Takayama</surname><given-names>S.</given-names></name><name><surname>Hattori</surname><given-names>T.</given-names></name><name><surname>Matsui</surname><given-names>R.</given-names></name><name><surname>Sakamoto</surname><given-names>M.</given-names></name><name><surname>Kani</surname><given-names>H.</given-names></name><name><surname>Kurokawa</surname><given-names>S.</given-names></name><name><surname>Fujiwara</surname><given-names>T.</given-names></name></person-group><article-title>Combined laparoscopic and robotic surgery for synchronous colorectal and genitourinary cancer: a case series</article-title><source>Int. J. Surg. Case Rep.</source><volume>51</volume><year>2018</year><fpage>323</fpage><lpage>327</lpage><comment>Epub 2018 Sep 18</comment><pub-id pub-id-type="pmid">30245354</pub-id></element-citation></ref><ref id="bib0045"><label>9</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Mori</surname><given-names>M.</given-names></name><name><surname>Shuto</surname><given-names>K.</given-names></name><name><surname>Kosugi</surname><given-names>C.</given-names></name><name><surname>Narushima</surname><given-names>K.</given-names></name><name><surname>Hayashi</surname><given-names>H.</given-names></name><name><surname>Matsubara</surname><given-names>H.</given-names></name><name><surname>Koda</surname><given-names>K.</given-names></name></person-group><article-title>An increase in the neutrophil-to-lymphocyte ratio during adjuvant chemotherapy indicates a poor prognosis in patients with stage II or III gastric cancer</article-title><source>BMC Cancer</source><volume>18</volume><issue>December (1)</issue><year>2018</year><fpage>1261</fpage><pub-id pub-id-type="pmid">30558575</pub-id></element-citation></ref><ref id="bib0050"><label>10</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H.Y.</given-names></name><name><surname>Chu</surname><given-names>C.H.</given-names></name><name><surname>Chang</surname><given-names>W.H.</given-names></name><name><surname>Hsu</surname><given-names>T.C.</given-names></name><name><surname>Lin</surname><given-names>S.C.</given-names></name><name><surname>Liu</surname><given-names>C.C.</given-names></name><name><surname>Yang</surname><given-names>A.M.</given-names></name><name><surname>Shih</surname><given-names>S.C.</given-names></name></person-group><article-title>Clinical analysis of multiple primary malignancies in the digestive system: a hospital-based study</article-title><source>World J. Gastroenterol.</source><volume>11</volume><issue>July (27)</issue><year>2005</year><fpage>4215</fpage><lpage>4219</lpage><pub-id pub-id-type="pmid">16015692</pub-id></element-citation></ref><ref id="bib0055"><label>11</label><element-citation publication-type="journal" id="sbref0055"><person-group person-group-type="author"><name><surname>O&#x02019;Sullivan</surname><given-names>M.</given-names></name><name><surname>Kearney</surname><given-names>D.E.</given-names></name><name><surname>Giri</surname><given-names>S.K.</given-names></name><name><surname>Coffey</surname><given-names>J.C.</given-names></name></person-group><article-title>Combined laparoscopic-assisted nephrectomy and complete mesocolic excision for synchronous renal and colon cancers</article-title><source>BMJ Case Rep.</source><volume>2015</volume><issue>September</issue><year>2015</year><comment>pii: bcr2015211681</comment></element-citation></ref><ref id="bib0060"><label>12</label><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Wadhwa</surname><given-names>A.</given-names></name><name><surname>Chowbey</surname><given-names>P.K.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Khullar</surname><given-names>R.</given-names></name><name><surname>Soni</surname><given-names>V.</given-names></name><name><surname>Baijal</surname><given-names>M.</given-names></name></person-group><article-title>Combined procedures in laparoscopic surgery</article-title><source>Surg. Laparosc. Endosc. Percutan. Tech.</source><volume>13</volume><issue>December (6)</issue><year>2003</year><fpage>382</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">14712100</pub-id></element-citation></ref><ref id="bib0065"><label>13</label><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Bakos</surname><given-names>O.</given-names></name><name><surname>Lawson</surname><given-names>C.</given-names></name><name><surname>Rouleau</surname><given-names>S.</given-names></name><name><surname>Tai</surname><given-names>L.H.</given-names></name></person-group><article-title>Combining surgery and immunotherapy: turning an immunosuppressive effect into a therapeutic opportunity</article-title><source>J. Immunother. Cancer</source><volume>6</volume><issue>September (1)</issue><year>2018</year><fpage>86</fpage><pub-id pub-id-type="pmid">30176921</pub-id></element-citation></ref><ref id="bib0070"><label>14</label><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Fukaya</surname><given-names>M.</given-names></name><name><surname>Abe</surname><given-names>T.</given-names></name><name><surname>Yokoyama</surname><given-names>Y.</given-names></name><name><surname>Itatsu</surname><given-names>K.</given-names></name><name><surname>Nagino</surname><given-names>M.</given-names></name></person-group><article-title>Two-stage operation for synchronous triple primary cancer of the esophagus, stomach, and ampulla of vater: report of a case</article-title><source>Surg. Today</source><volume>44</volume><issue>May (5)</issue><year>2014</year><fpage>967</fpage><lpage>971</lpage><comment>Epub 2013 Mar 17</comment><pub-id pub-id-type="pmid">23504004</pub-id></element-citation></ref><ref id="bib0075"><label>15</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Tai</surname><given-names>L.H.</given-names></name><name><surname>de Souza</surname><given-names>C.T.</given-names></name><name><surname>B&#x000e9;langer</surname><given-names>S.</given-names></name><name><surname>Ly</surname><given-names>L.</given-names></name><name><surname>Alkayyal</surname><given-names>A.A.</given-names></name><name><surname>Zhang</surname><given-names>J.</given-names></name><name><surname>Rintoul</surname><given-names>J.L.</given-names></name><name><surname>Ananth</surname><given-names>A.A.</given-names></name><name><surname>Lam</surname><given-names>T.</given-names></name><name><surname>Breitbach</surname><given-names>C.J.</given-names></name><name><surname>Falls</surname><given-names>T.J.</given-names></name><name><surname>Kirn</surname><given-names>D.H.</given-names></name><name><surname>Bell</surname><given-names>J.C.</given-names></name><name><surname>Makrigiannis</surname><given-names>A.P.</given-names></name><name><surname>Auer</surname><given-names>R.A.</given-names></name></person-group><article-title>Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells</article-title><source>Cancer Res.</source><volume>1</volume><issue>January (1)</issue><year>2013</year><fpage>97</fpage><lpage>107</lpage><comment>Epub 2012 Oct 22</comment></element-citation></ref><ref id="bib0080"><label>16</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Tsuchiya</surname><given-names>Y.</given-names></name><name><surname>Sawada</surname><given-names>S.</given-names></name><name><surname>Yoshioka</surname><given-names>I.</given-names></name><name><surname>Ohashi</surname><given-names>Y.</given-names></name><name><surname>Matsuo</surname><given-names>M.</given-names></name><name><surname>Harimaya</surname><given-names>Y.</given-names></name><name><surname>Tsukada</surname><given-names>K.</given-names></name><name><surname>Saiki</surname><given-names>I.</given-names></name></person-group><article-title>Increased surgical stress promotes tumor metastasis</article-title><source>Surgery</source><volume>133</volume><issue>May (5)</issue><year>2003</year><fpage>547</fpage><lpage>555</lpage><pub-id pub-id-type="pmid">12773983</pub-id></element-citation></ref><ref id="bib0085"><label>17</label><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Wilt</surname><given-names>T.J.</given-names></name><name><surname>Brawer</surname><given-names>M.K.</given-names></name><name><surname>Jones</surname><given-names>K.M.</given-names></name><name><surname>Barry</surname><given-names>M.J.</given-names></name><name><surname>Aronson</surname><given-names>W.J.</given-names></name><name><surname>Fox</surname><given-names>S.</given-names></name><name><surname>Gingrich</surname><given-names>J.R.</given-names></name><name><surname>Wei</surname><given-names>J.T.</given-names></name><name><surname>Gilhooly</surname><given-names>P.</given-names></name><name><surname>Grob</surname><given-names>B.M.</given-names></name><name><surname>Nsouli</surname><given-names>I.</given-names></name><name><surname>Iyer</surname><given-names>P.</given-names></name><name><surname>Cartagena</surname><given-names>R.</given-names></name><name><surname>Snider</surname><given-names>G.</given-names></name><name><surname>Roehrborn</surname><given-names>C.</given-names></name><name><surname>Sharifi</surname><given-names>R.</given-names></name><name><surname>Blank</surname><given-names>W.</given-names></name><name><surname>Pandya</surname><given-names>P.</given-names></name><name><surname>Andriole</surname><given-names>G.L.</given-names></name><name><surname>Culkin</surname><given-names>D.</given-names></name><name><surname>Wheeler</surname><given-names>T.</given-names></name><name><surname>Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group</surname></name></person-group><article-title>Radical prostatectomy versus observation for localized prostate cancer</article-title><source>N. Engl. J. Med.</source><volume>367</volume><issue>July (3)</issue><year>2012</year><fpage>203</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">22808955</pub-id></element-citation></ref><ref id="bib0090"><label>18</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Tsurumaki Sato</surname><given-names>Y.</given-names></name><name><surname>Fukuhara</surname><given-names>H.</given-names></name><name><surname>Suzuki</surname><given-names>M.</given-names></name><name><surname>Fujimura</surname><given-names>T.</given-names></name><name><surname>Nakagawa</surname><given-names>T.</given-names></name><name><surname>Nishimatsu</surname><given-names>H.</given-names></name><name><surname>Kume</surname><given-names>H.</given-names></name><name><surname>Morikawa</surname><given-names>T.</given-names></name><name><surname>Fukayama</surname><given-names>M.</given-names></name><name><surname>Homma</surname><given-names>Y.</given-names></name></person-group><article-title>Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer</article-title><source>BMC Urol.</source><volume>29</volume><issue>January (14)</issue><year>2014</year><fpage>13</fpage></element-citation></ref><ref id="bib0095"><label>19</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>Taguchi</surname><given-names>S.</given-names></name><name><surname>Fukuhara</surname><given-names>H.</given-names></name><name><surname>Azuma</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>M.</given-names></name><name><surname>Fujimura</surname><given-names>T.</given-names></name><name><surname>Nakagawa</surname><given-names>T.</given-names></name><name><surname>Ishikawa</surname><given-names>A.</given-names></name><name><surname>Kume</surname><given-names>H.</given-names></name><name><surname>Igawa</surname><given-names>Y.</given-names></name><name><surname>Homma</surname><given-names>Y.</given-names></name></person-group><article-title>Ultra-early versus early salvage androgen deprivation therapy for post-prostatectomy biochemical recurrence in pT2-4N0M0 prostate cancer</article-title><source>BMC Urol.</source><volume>16</volume><issue>October (14)</issue><year>2014</year><fpage>81</fpage></element-citation></ref><ref id="bib0100"><label>20</label><element-citation publication-type="journal" id="sbref0100"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Shelley</surname><given-names>M.</given-names></name><name><surname>Harrison</surname><given-names>C.</given-names></name><name><surname>Coles</surname><given-names>B.</given-names></name><name><surname>Wilt</surname><given-names>T.J.</given-names></name><name><surname>Mason</surname><given-names>M.D.</given-names></name></person-group><article-title>Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer</article-title><source>Cochrane Database Syst Rev.</source><volume>18</volume><issue>October (4)</issue><year>2006</year><fpage>CD006019</fpage></element-citation></ref></ref-list></back></article>